High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy
Sign Up to like & getrecommendations! Published in 2018 at "Brain, Behavior, and Immunity"
DOI: 10.1016/j.bbi.2017.10.008
Abstract: Approximately 30% of epilepsy patients experience seizures that are not controlled by the available drugs. Moreover, these drugs provide mainly a symptomatic treatment since they do not interfere with the disease's mechanisms. A mechanistic approach… read more here.
Keywords: high mobility; group box; mobility group; brain ... See more keywords
Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor
Sign Up to like & getrecommendations! Published in 2022 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.02805-22
Abstract: Gut dysbiosis-altered metabolite association exhibits specific and convincing utility to differentiate CKD associated with distinct pathogenic factor. These results present the validity of pathogenesis-associated markers across healthy participants and high-risk population toward the early screening,… read more here.
Keywords: pathogenic factor; gut; distinct pathogenic; chronic kidney ... See more keywords
The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24119605
Abstract: S100B is a calcium-binding protein mainly concentrated in astrocytes in the nervous system. Its levels in biological fluids are recognized as a reliable biomarker of active neural distress, and more recently, mounting evidence points to… read more here.
Keywords: s100b protein; pathogenic factor; biomarker;